Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
JC Hopewell, S Parish, A Offer, E Link… - European heart …, 2013 - academic.oup.com
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
JC Hopewell, S Parish, A Offer, E Link… - European Heart …, 2012 - europepmc.org
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
[PDF][PDF] Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
JC Hopewell, S Parish, A Offer… - European Heart …, 2013 - pdfs.semanticscholar.org
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
[引用][C] Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
JC Hopewell, S Parish, A Offer, E Link, R Clarke… - European Heart …, 2012 - cir.nii.ac.jp
Impact of common genetic variation on response to simvastatin therapy among 18 705
participants in the Heart Protection Study | CiNii Research CiNii 国立情報学研究所 学術情報 …
participants in the Heart Protection Study | CiNii Research CiNii 国立情報学研究所 学術情報 …
[HTML][HTML] Editor's choice: Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
JC Hopewell, S Parish, A Offer, E Link… - European Heart …, 2013 - ncbi.nlm.nih.gov
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
[PDF][PDF] Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
JC Hopewell, S Parish, A Offer, E Link… - European Heart …, 2013 - researchgate.net
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
JC Hopewell, S Parish, A Offer, E Link, R Clarke… - 2013 - pubmed.ncbi.nlm.nih.gov
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
J Hopewell, S Parish, A Offer, E Link, R Clarke… - European heart …, 2013 - ora.ox.ac.uk
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
JC Hopewell, S Parish, A Offer, E Link… - European Heart …, 2013 - search.ebscohost.com
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
[PDF][PDF] Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
JC Hopewell, S Parish, A Offer, E Link, R Clarke - European Heart Journal, 2013 - Citeseer
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …
uncertain whether there is clinically relevant genetic variation in their efficacy. This study of …